Document is current
Any future updates will be listed below
-
Authors
Xu, Xun http://orcid.org/0000-0002-7813-854X
Wang, Weiwei http://orcid.org/0000-0002-2831-885X
Liu, Yue
Bäckemo, Johan http://orcid.org/0000-0001-6721-8109
Heuchel, Matthias http://orcid.org/0000-0002-3860-1835
Wang, Wei
Nie, Yan http://orcid.org/0000-0002-2178-0574
Iqbal, Imran http://orcid.org/0000-0001-7031-6674
Kratz, Karl
Lendlein, Andreas http://orcid.org/0000-0003-4126-4670
-
Funding
Funding for this research was provided by:
Helmholtz Association (Program-oriented funding, I2B Funds, AIOrganoid, Helmholtz Cross Programme Initiative, VH-GS-503, I2B Funds, AIOrganoid, I2B Funds, AIOrganoid, Program-oriented funding, Program-oriented funding, Program-oriented funding, Program-oriented funding, Program-oriented funding, AIOrganoid, Program-oriented funding, I2B Funds, Program-oriented funding, Program-oriented funding)
Bundesministerium für Bildung und Forschung (13GW0098, 13GW0099)
China Scholarship Council (No. 202206170040)
Helmholtz Virtuelles Institut Multifunktionale Biomaterialien für die Medizin (VH-VI-423)
- License Information
-
More Information
Article History
Received: 7 July 2022
Accepted: 11 July 2024
First Online: 12 August 2024
Change Date: 20 September 2024
Change Type: Update
Change Details: In the version of the article initially published, Andreas Lendlein’s email was incorrect and has now been amended to andreas.lendlein@gmail.com in the HTML and PDF versions of the article.
Competing interests
: A.L. and K.K. are inventors of a patent (WO 2011/054601 (A1)), related to cell culture inserts. X.X., Weiwei Wang and N.M. are inventors on a provisional patent application (EP 24160389.3 and 24161228.2) covering the biophysical methods for naivety reversion. The remaining authors declare no competing interests.
